|
|
|
Volumn 23, Issue 1 SUPPL. 2, 1996, Pages 76-81
|
|
Implications of the new biology for therapy in breast cancer
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANGIOGENIC FACTOR;
BASIC FIBROBLAST GROWTH FACTOR;
COLLAGENASE;
EPIDERMAL GROWTH FACTOR;
FUMAGILLOL CHLOROACETYLCARBAMATE;
GELATINASE;
GELATINASE B;
GROWTH FACTOR;
INTEGRIN;
LAMININ;
MATRIX METALLOPROTEINASE;
METALLOPROTEINASE;
METALLOPROTEINASE INHIBITOR;
MONOCLONAL ANTIBODY;
PENTOSAN POLYSULFATE;
PROTEIN TYROSINE KINASE;
SCLEROPROTEIN;
SURAMIN;
THROMBOSPONDIN;
VASCULOTROPIN;
APOPTOSIS;
BREAST CANCER;
CANCER GROWTH;
CANCER INHIBITION;
CANCER INVASION;
CLINICAL TRIAL;
HUMAN;
METASTASIS;
NEOVASCULARIZATION (PATHOLOGY);
ONCOGENE NEU;
PRIORITY JOURNAL;
PROGNOSIS;
RECEPTOR UPREGULATION;
REVIEW;
ANGIOGENESIS INDUCING AGENTS;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BIOLOGY;
BREAST NEOPLASMS;
FEMALE;
GROWTH INHIBITORS;
GROWTH SUBSTANCES;
HUMANS;
METALLOENDOPEPTIDASES;
NEOPLASM INVASIVENESS;
NEOPLASM METASTASIS;
NEOVASCULARIZATION, PATHOLOGIC;
PROGNOSIS;
RECEPTORS, GROWTH FACTOR;
TREATMENT OUTCOME;
UP-REGULATION;
|
|
EID: 0029993344
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (23)
|
|
References (0)
|
